Group One Trading
LFCR icon

Group One Trading’s Lifecore Biomedical LFCR Stock Holding History

Group One Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.32K Sell
1,700
-300
-15% -$2.07K ﹤0.01% 6604
2025
Q4 		$16.4K Sell
2,000
-1,300
-39% -$9.62K ﹤0.01% 6506
2025
Q3 		$24.3K Buy
3,300
+2,300
+230% +$17.4K ﹤0.01% 6551
2025
Q2 		$8.12K Sell
1,000
-2,500
-71% -$16.9K ﹤0.01% 6840
2025
Q1 		$24.6K Buy
3,500
+1,500
+75% +$9.32K ﹤0.01% 5678
2024
Q4 		$14.9K Sell
2,000
-1,900
-49% -$12.1K ﹤0.01% 5886
2024
Q3 		$19.2K Sell
3,900
-5,300
-58% -$27.7K ﹤0.01% 5250
2024
Q2 		$47.2K Buy
9,200
+1,500
+19% +$8.88K ﹤0.01% 4559
2024
Q1 		$40.9K Buy
7,700
+5,200
+208% +$37.2K ﹤0.01% 4878
2023
Q4 		$15.5K Sell
2,500
-11,700
-82% -$81.2K ﹤0.01% 5932
2023
Q3 		$107K Sell
14,200
-32,100
-69% -$293K ﹤0.01% 4388
2023
Q2 		$448K Buy
46,300
+45,900
+11,475% +$280K ﹤0.01% 3131
2023
Q1 		$1.51K Buy
+400
New +$2.23K ﹤0.01% 6680
2022
Q4 		– Sell
-800
Closed -$71K – 7706
2022
Q3 		$71K Buy
+800
New +$8.13K ﹤0.01% 5102
2013
Q4 		– Sell
-2,000
Closed -$24K – 5383
2013
Q3 		$24K Sell
2,000
-6,200
-76% -$86.5K ﹤0.01% 4057
2013
Q2 		$108K Buy
+8,200
New +$113K ﹤0.01% 2745

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's LFCR Position: Q2 2025 in Review

Group One Trading sold out of Lifecore Biomedical (LFCR) in Q2 2025, closing a stake of 4,300 shares — an estimated $29K sold.

Group One Trading first reported a position in LFCR in Q2 2013 and held it in 11 quarters. The position peaked at $113K in Q3 2023. 86 funds tracked by Wall St. Rank hold LFCR as of Q2 2025.

  • Group One Trading reported no remaining Lifecore Biomedical position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 4,300 Lifecore Biomedical shares in Q2 2025, an estimated $29K.
  • Group One Trading first reported a position in Lifecore Biomedical in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Lifecore Biomedical position peaked at $113K in Q3 2023.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.